Outcomes of Intravenous Tocilizumab Treatment for Refractory Pars Planitis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Outcomes of Intravenous Tocilizumab Treatment for Refractory Pars Planitis

Published:2024-05-23 Issue: Volume: Page:1-6
ISSN:0927-3948
Container-title:Ocular Immunology and Inflammation
language:en
Short-container-title:Ocular Immunology and Inflammation

Author:

Kongrat Lisa¹²^ORCID,Maleki Arash²³^ORCID,Rujkorakarn Ploysai¹²^ORCID,Margolis Michael J.¹²^ORCID,Valerio Tate¹²^ORCID,Massoudi Yasmin¹²^ORCID,Anesi Stephen D.¹²^ORCID,Foster C. Stephen¹²⁴^ORCID

Affiliation:

1. Ophthalmology, Massachusetts Eye Research and Surgery Institution, Waltham, Massachusetts, USA

2. The Ocular Immunology and Uveitis Foundation, Waltham, Massachusetts, USA

3. Department of Ophthalmology, University of Florida, Gainesville, Florida, USA

4. Department of Ophthalmology, Harvard Medical School, Cambridge, Massachusetts, USA

Funder

Mallinckrodt

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/09273948.2024.2354751

Reference38 articles.

1. Childhood pars planitis; clinical features and outcomes;Nikkhah H;J Ophthalmic Vis Res,2011

2. Pediatric uveitis in Southern Turkey

3. Epidemiology and Course of Disease in Childhood Uveitis

4. Ocular complications of pediatric uveitis

5. Patterns of childhood-onset uveitis in a referral center in Turkey

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP